Disruption of Transcriptionally Active Stat3 Dimers with Non‐phosphorylated, Salicylic Acid‐Based Small Molecules: Potent in vitro and Tumor Cell Activities

Signal transducer and activator of transcription 3 (Stat3) protein is a cytosolic transcription factor that relays signals from receptors in the plasma membrane directly to the nucleus, and is routinely hyperactivated in many human cancers and diseases.[1] Regarded as an oncogene, Stat3 is well-recognized as a master regulator of cellular events that lead to the cancer phenotype, making this protein viable target for molecular therapeutic design.[2] Stat3 inhibitors have included peptides,[3–4] peptidomimetics,[5–9] small molecules[10–14] and metal complexes.[15] Despite significant advances in Stat3 inhibition,[1] truly potent (in vivo), isoform-selective, small molecule Stat3 agents have not been readily forthcoming; this is likely due in part to the challenge of disrupting protein–protein interactions.[16]

[1]  J. Wrana,et al.  Inhibition of the sodium potassium adenosine triphosphatase pump sensitizes cancer cells to anoikis and prevents distant tumor formation. , 2009, Cancer research.

[2]  P. Yue,et al.  Targeting STAT3 in cancer: how successful are we? , 2009, Expert opinion on investigational drugs.

[3]  William P. Katt,et al.  Targeting Protein–Protein Interactions: Suppression of Stat3 Dimerization with Rationally Designed Small‐Molecule, Nonpeptidic SH2 Domain Binders , 2008, Chembiochem : a European journal of chemical biology.

[4]  T. Berg.  Signal Transducers and Activators of Transcription as Targets for Small Organic Molecules , 2008, Chembiochem : a European journal of chemical biology.

[5]  J. Turkson,et al.  Molecular Approaches towards the Inhibition of the Signal Transducer and Activator of Transcription 3 (Stat3) Protein , 2008, ChemMedChem.

[6]  S. Fletcher,et al.  Mild, efficient and rapid O-debenzylation of ortho-substituted phenols with trifluoroacetic acid , 2008 .

[7]  William P. Katt,et al.  An oxazole-based small-molecule Stat3 inhibitor modulates Stat3 stability and processing and induces antitumor cell effects. , 2007, ACS chemical biology.

[8]  Shaomeng Wang,et al.  Design and synthesis of a new, conformationally constrained, macrocyclic small-molecule inhibitor of STAT3 via 'click chemistry'. , 2007, Bioorganic & medicinal chemistry letters.

[9]  Sheng Zhang,et al.  PTP1B as a drug target: recent developments in PTP1B inhibitor discovery. , 2007, Drug discovery today.

[10]  H. Sajiki,et al.  Pd/C(en) catalyzed chemoselective hydrogenation in the presence of aryl nitriles. , 2007, Chemical & pharmaceutical bulletin.

[11]  Steven Fletcher,et al.  Protein-protein interaction inhibitors: small molecules from screening techniques. , 2007, Current topics in medicinal chemistry.

[12]  W. Guida,et al.  Selective chemical probe inhibitor of Stat3, identified through structure-based virtual screening, induces antitumor activity , 2007, Proceedings of the National Academy of Sciences.

[13]  William P. Katt,et al.  Isoform selective inhibition of STAT1 or STAT3 homo-dimerization via peptidomimetic probes: structural recognition of STAT SH2 domains. , 2007, Bioorganic & medicinal chemistry letters.

[14]  J. McMurray,et al.  Solid-phase synthesis of Stat3 inhibitors incorporating O-carbamoylserine and O-carbamoylthreonine as glutamine mimics. , 2007, Bioorganic & medicinal chemistry letters.

[15]  Bianca Sperl,et al.  Stattic: a small-molecule inhibitor of STAT3 activation and dimerization. , 2006, Chemistry & biology.

[16]  S. Fletcher,et al.  Targeting protein–protein interactions by rational design: mimicry of protein surfaces , 2006, Journal of The Royal Society Interface.

[17]  Hong Xin,et al.  DU‐145 and PC‐3 human prostate cancer cell lines express androgen receptor: Implications for the androgen receptor functions and regulation , 2006, FEBS letters.

[18]  Steven Fletcher,et al.  Protein surface recognition and proteomimetics: mimics of protein surface structure and function. , 2005, Current opinion in chemical biology.

[19]  Arlin G. Cameron,et al.  Investigation of the binding determinants of phosphopeptides targeted to the SRC homology 2 domain of the signal transducer and activator of transcription 3. Development of a high-affinity peptide inhibitor. , 2005, Journal of medicinal chemistry.

[20]  J. Darnell,et al.  Validating Stat3 in cancer therapy , 2005, Nature Medicine.

[21]  Renxiao Wang,et al.  A low-molecular-weight compound discovered through virtual database screening inhibits Stat3 function in breast cancer cells. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[22]  J. Turkson,et al.  Inhibition of constitutive signal transducer and activator of transcription 3 activation by novel platinum complexes with potent antitumor activity. , 2004, Molecular cancer therapeutics.

[23]  T. Berg,et al.  A high-throughput fluorescence polarization assay for signal transducer and activator of transcription 3. , 2004, Analytical biochemistry.

[24]  J. McMurray,et al.  Identification of a high-affinity phosphopeptide inhibitor of Stat3. , 2003, Bioorganic & medicinal chemistry letters.

[25]  J. Pow-Sang,et al.  Constitutive activation of Stat3 in human prostate tumors and cell lines: direct inhibition of Stat3 signaling induces apoptosis of prostate cancer cells. , 2002, Cancer research.

[26]  R. Jove,et al.  Activated STAT signaling in human tumors provides novel molecular targets for therapeutic intervention. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[27]  J. Turkson,et al.  Phosphotyrosyl Peptides Block Stat3-mediated DNA Binding Activity, Gene Regulation, and Cell Transformation* , 2001, The Journal of Biological Chemistry.

[28]  Jiayuh Lin,et al.  Inhibition of constitutively active Stat3 suppresses growth of human ovarian and breast cancer cells , 2001, Oncogene.

[29]  R. Sinha,et al.  Heterocyclic amines (HCAS) and risk of breast cancer , 2001, Breast Cancer Research.

[30]  Hua Yu,et al.  Constitutive activation of Stat3 by the Src and JAK tyrosine kinases participates in growth regulation of human breast carcinoma cells , 2001, Oncogene.

[31]  Roy Garcia,et al.  STATs in oncogenesis , 2000, Oncogene.

[32]  S. Becker,et al.  Three-dimensional structure of the Stat3β homodimer bound to DNA , 1998, Nature.

[33]  J. Darnell.  STATs and gene regulation. , 1997, Science.

[34]  P Willett,et al.  Development and validation of a genetic algorithm for flexible docking. , 1997, Journal of molecular biology.

[35]  Darnell Je.  The JAK-STAT pathway: summary of initial studies and recent advances. , 1996 .

[36]  M. Minden,et al.  Expression of a retinoic acid receptor gene in myeloid leukemia cells. , 1989, Leukemia.

[37]  J. Trent,et al.  Epidermal growth factor receptor gene-amplified MDA-468 breast cancer cell line and its nonamplified variants , 1987, Molecular and cellular biology.

[38]  P. N. Pandey,et al.  Palladium-Catalyzed Hydrodehalogenation of Haloaromatic Compounds , 1982 .